Evaluation of Patients with Ischemic Stroke Receiving iv t-PA in the Emergency Department

Basit Öğe Kaydı
dc.authorwosidBaykan, Necmi/AAR-7922-2021
dc.contributor.authorSalt, Omer
dc.contributor.authorBaykan, Necmi
dc.contributor.authorKaymaz, Nesij Dogan
dc.contributor.authorYakar, Sule
dc.contributor.authorDonmez, Halil
dc.contributor.authorKoseoglu, Emel
dc.contributor.authorDurukan, Polat
dc.date.accessioned2024-06-12T11:00:16Z
dc.date.available2024-06-12T11:00:16Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstractAim: The aim of the present study was to determine the demographic characteristics, localization of emboli, imaging findings, National Institutes of Health Stroke Scale (NIHSS) scores, and complications of patients who received intravenous (iv) tissue plasminogen activator (t-PA) due to early period of ischemic cerebrovascular disease (CVD) during the 6-year period in a tertiary level emergency department of a university hospital. Materials and Methods: The study was retrospectively performed in 65 patients aged >= 18 years and who underwent iv t-PA with a diagnosis of ischemic CVD. Demographic data, such as age, gender, and smoking, were obtained by examining the medical records of the patients. The baseline Glasgow Coma Scale, NIHSS, start time of the event, time of admission to the hospital, and prognosis of the patients were recorded. Results: Intracranial hemorrhage was detected in 16.9% of the patients after treatment. On examination of the patients' outcome, a total of 32.3% (n=21) died after therapy. A significant correlation was observed between high NIHSS score and complications. Conclusion: In our study, a high NIHSS score at the time of admission has been found to increase both the risk of intracerebral hemorrhagic complication and mortality. We hypothesize that iv t-PA treatment gives successful results despite the complications, and emergency physicians should be more courageous in their application.en_US
dc.identifier.doi10.5152/eajem.2018.30922
dc.identifier.endpage54en_US
dc.identifier.issn2149-5807
dc.identifier.issn2149-6048
dc.identifier.issue2en_US
dc.identifier.startpage50en_US
dc.identifier.urihttps://doi.org/10.5152/eajem.2018.30922
dc.identifier.urihttps://hdl.handle.net/20.500.14551/20770
dc.identifier.volume17en_US
dc.identifier.wosWOS:000440341900004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEurasian Journal Of Emergency Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEmergency Medicineen_US
dc.subjectIschemic Strokeen_US
dc.subjectTissue Plasminogen Activatoren_US
dc.subjectTissue-Plasminogen Activatoren_US
dc.subjectIntracerebral Hemorrhageen_US
dc.subjectIntravenous Thrombolysisen_US
dc.subject3 Hen_US
dc.subjectMrien_US
dc.titleEvaluation of Patients with Ischemic Stroke Receiving iv t-PA in the Emergency Departmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu

Kişisel bilgilerinizi şu amaçlarla toplar ve işleriz: Kimlik Doğrulama, Tercihler, Onay ve İstatistikler.
Daha fazla bilgi edinmek için lütfen gizlilik politikası sayfamızı okuyun.

Özelleştirme